First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...